Some providers are more conservative, holding at lower doses for six to eight weeks before escalating
Body Mass Index (BMI) is used to determine eligibility for GLP-1 Plans
A retatrutide calculator automates this formula so you do not have to do manual math each time
Consider clinical review and patient engagement tools, such as prior authorization and custom care plans, to ensure members meet clinical criteria before starting on GLP-1s and members continue treatment for effective, long-term results
Note: Phase 2 trials also tested a 1 mg starting dose, which showed modest results
1j, k), and overexpression of VAPB P56S, but not of WT VAPB (Supplementary Fig